Publications by authors named "M Faehling"

Claim this Profile
F
Follow-up Algorithm for Detecting Chronic Sequelae of Pulmonary Embolism: Diagnostic Performance and Possible Limitations.
Ioannis T Farmakis, Luca Valerio, Stefano Barco, Lukas Hobohm, Katharina Mohr, Martin Faehling

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of brain metastases and survival in lung adenocarcinoma with KRAS or EFGR mutation.
Martin Faehling, Sabine Fallscheer, Julia Schmiederer, Jörn Sträter, Petros Christopoulos

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study.
Rajiv Shah, Eva L Buchmeier, Hans-Georg Kopp, Daniel C Christoph, Frank Griesinger, Martin Faehling

Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).
Farastuk Bozorgmehr, Inn Chung, Jürgen R Fischer, Marc Bischof, Akin Atmaca, Martin Faehling

Clin Exp Metastasis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.
Martin Faehling, Sabine Fallscheer, Birgit Schwenk, Harald Seifarth, Jörn Sträter

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis